Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians

• Status: COMPLETED
• Trial end date: 2021-11-01

Summary

Our study aimed to investigate the efficacy and safety of hybrid regimen as a first line therapy for H. pylori eradication compared to triple and quadruple regimens in attempt to overcome antibiotic resistance

• Phase: PHASE4

Details

• Lead Sponsor: Helwan University
• Treatments: Amoxicillin; Clarithromycin; Metronidazole; Omeprazole; Tablets